Stay updated on Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy
Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page.
Latest updates to the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version 2.10.0, adding three more interventions/treatments and noting that the study now has 56 locations.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the web page content.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent change in the webpage content.SummaryDifference0.0%
- Check32 days agoChange DetectedThe value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less MedlinePlus Genetics related topics: Breast cancer MedlinePlus related topics: Breast Cancer Drug Information available for: Trastuzumab Pertuzumab FDA Drug and Device Resources'. This change represents an update in the information displayed on the webpage related to the study on Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.SummaryDifference89%
Stay in the know with updates to Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page.